Canara Robeco Small Cap Fund
The scheme seeks to generate capital appreciation by investing predominantly in Small Cap stocks.
Growthvine rating: 2/5 — ranked #22 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹37.45 (as of 2026-10-22) |
|---|
| AUM | ₹13,972 Cr |
|---|
| Expense ratio | 1.46% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Pranav Gokhale |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 12.39% |
|---|
| Sharpe ratio | 0.32 |
|---|
| Standard deviation | 18.19% |
|---|
| Max drawdown | −36.30% |
|---|
| Alpha | -0.91 |
|---|
| Beta | 0.81 |
|---|
Over 5 years, captured 78.7% of NIFTY Smallcap 250's upside and 74.6% of its downside.
Market cap allocation
| Large cap | 6.4% |
|---|
| Mid cap | 14.8% |
|---|
| Small cap | 78.7% |
|---|
Concentration
| Top 5 holdings | 12.7% |
|---|
| Top 10 holdings | 23.3% |
|---|
| Total holdings | 94 |
|---|
| Index overlap | 25.3% |
|---|
| Active share | 74.7% |
|---|
Top holdings
- TREPS — 3.6%
- Multi Commodity Exchange of India Ltd — 2.7%
- RBL Bank Limited — 2.7%
- TBO TEK LIMITED — 2.5%
- Eternal Limited — 2.4%
- Karur Vysya Bank Ltd. — 2.3%
- Gland Pharma Limited — 2.3%
- City Union Bank Ltd — 2.2%
- PNB Housing Finance Limited — 2.1%
- AFFLE 3I LIMITED — 2.0%
Top sectors
- Banking & Financial — 16.5%
- Industrial Products — 9.6%
- Pharma & Biotech — 8.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −2.6% | Q4 (Bottom) | #33 of 34 |
| 2025 | −4.5% | Q3 | #16 of 30 |
| 2024 | 23.2% | Q3 | #20 of 28 |
| 2023 | 32.3% | Q4 (Bottom) | #22 of 24 |
| 2022 | 6.8% | Q1 (Top) | #4 of 22 |